Domatinostat Plus Avelumab for Previously Treated Mismatch Repair–Proficient Advanced Oesophagogastric and Colorectal Adenocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGE
ESMO Open 2024 Apr 01;9(4)102971, E Cartwright, S Slater, C Saffery, A Tran, F Turkes, G Smith, M Aresu, D Kohoutova, M Terlizzo, O Zhitkov, I Rana, EW Johnston, I Sanna, E Smyth, W Mansoor, C Fribbens, S Rao, I Chau, N Starling, D CunninghamFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.